摘要
非酒精性脂肪性肝病是目前最常见的慢性肝病之一,尚缺乏特效的治疗药物。近年来研究结果表明中药单体可通过多靶点、多通路治疗非酒精性脂肪性肝病,具有潜在优势。现对中药单体治疗NAFLD的研究进展作一综述。
Non-alcoholic fatty liver disease is one of the most common chronic liver diseases, and there is still no specific treatment for it. In recent years, the results show that Chinese medicine monomer can have non-alcoholic fatty liver disease through multiple targets and multiple pathways, which has potential advantages. The research progress of traditional Chinese medicine monomer treatment of NAFLD is reviewed.
作者
李珊珊
陈少彬
龚先琼
LI Shan-shan1,CHEN Shao-bin1,GONG Xian-qiong2(1.Fujian University of Traditional Chinese Medicine,Fuzhou 351012,Fujian,China;2.Liver Disease Center,Xiamen Hospital of Traditional Chinese Medicine,Fujian University of Traditional Chinese Medicine,Xiamen 361009,Fujian,China)
出处
《医学信息》
2018年第21期24-27,32,共5页
Journal of Medical Information
基金
国家自然科学基金腺苷酸活化蛋白激酶异常激活促进肝细胞凋亡:内毒素诱导肝损伤发病新机制及干预新靶点(编号:81600465)
关键词
非酒精性脂肪性肝病
中药单体
中药治疗
Non-alcoholic fatty liver disease
Chinese medicine monomer
Chinese medicine treatment
